Developer docs
API playgroundTry for free, no card

Search company profiles

TaBlitz Labs

Full company profile

uuid0226iql

Namestring
TaBlitz Labs
Legal namestring
TaBlitz Labs
Websiteurl
tablitz.us
Company typeenum
Private
Founded yearint
2023
Descriptiontext

TaBlitz Labs is a U.S.-based pharmaceutical technology company founded in 2023 and headquartered in St. Louis. It operates as an "AI CDMO partner," providing formulation development, analytical, and material characterization services to pharmaceutical, nutraceutical, and animal health organizations. The company serves two customer tracks: end-user organizations seeking preformulation through scale-up formulation support, and contract development and manufacturing organizations (CDMOs/CMOs) that license the company's technology to deliver AI-driven tablet development capabilities to their own clients.

The company's core technology comprises two components: TaBlitz AI, a deep learning engine applied to tablet design and optimization that delivers data-driven recommendations for manufacturability, tool life, and performance; and the TaBlitz Platform for particle and tablet analytics, built on powder characterization practice aligned with USP <1062> and Pharmeuropa 5.44. These are complemented by Formulation and Development Services including preformulation, formulation development, and troubleshooting grounded in rigorous powder characterization. Revenue is generated through two streams: professional services engagements and technology licensing/implementation for CDMOs and CMOs. Pricing is not publicly disclosed and follows a contact-sales model. The go-to-market motion is sales-led, supported by participation in specialist training programs and the Compaction Simulation Forum, direct enterprise outreach, and a website displaying an enterprise customer logo lineup spanning Pfizer, Vertex Pharmaceuticals, Zentiva, Catalent, Haleon, Alkaloid Pharmaceuticals, Pharma Nord, Takeda, and Elanco.

Short descriptiontext

TaBlitz Labs is a U.S. pharmaceutical technology company offering AI-driven tablet formulation development, powder characterization, and scale-up services to pharmaceutical, nutraceutical, and animal health organizations, alongside technology licensing to CDMOs and CMOs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSt Louis, United States
HQ citystring
St Louis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pharmaceutical formulation services, tablet development AI, powder characterization, CDMO technology platform, analytical method development
Industry4 codes
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAIALAD
CMC & Pharmaceutical Development (Formulation/Process/Analytical Development)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)
NAICS code4 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing32541
  • Analytical Laboratory Instrument Manufacturing334516
  • Scientific Research and Development Services5417
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Pharmaceutical Preparations2834
  • Laboratory Analytical Instruments3826
Product category
Pharmaceutical Formulation Technology
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Formulation and Development Services
TypeProfessional Services
Description

Preformulation, formulation development, and troubleshooting services grounded in rigorous powder characterization and aligned with regulatory expectations, targeting organizations seeking formulation support and development services.

tablitzlabs.com
2Technology Licensing and Implementation
TypeLicensing Royalties
Description

Technology implementation services for CDMOs and CMOs who want to implement TaBlitz technology to offer the full TaBlitz advantage to their own clients, including platform access and AI capabilities.

tablitzlabs.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

TaBlitz Labs operates as an AI CDMO partner delivering formulation development services alongside a proprietary software platform (TaBlitz AI and TaBlitz Platform) for tablet and powder characterization. The company combines deep learning, formulation science, and mechanical principles to help pharmaceutical and nutraceutical organizations accelerate tablet development, reduce scale-up risk, and align with regulatory references including USP <1062> and Pharmeuropa 5.44. Revenue is generated through formulation/development services, technology licensing and implementation, and equipment sales/instrument partnerships.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Reduces development time through holistic, science-driven approaches and comprehensive characterization
+1 more record
Product overview1 text field

TaBlitz Labs offers a unified platform architecture centered on the TaBlitz AI engine and TaBlitz Platform for particle and tablet analytics. TaBlitz AI applies deep learning to tablet design and optimization, delivering data-driven recommendations for manufacturability, tool life, and performance. The TaBlitz Platform supports particle and tablet analytics built on powder characterization practice aligned with USP <1062> and Pharmeuropa 5.44. These technology offerings are complemented by Formulation & Development Services covering preformulation through scale-up.

Product and service3 records
1TaBlitz AI
CategoryAI software platform
Description

Proprietary deep-learning model that supports tablet and powder formulation development for pharmaceutical, nutraceutical, and CDMO organizations.

2TaBlitz Platform
CategoryAnalytical software platform
Description

Software platform for automated tablet and powder characterization, designed to integrate with laboratory instruments and align with regulatory references such as USP <1062> and Pharmeuropa 5.44.

3Formulation and Development Services
CategoryPharmaceutical CDMO services
Description

Professional formulation and development services delivered by TaBlitz Labs as an AI CDMO partner, leveraging TaBlitz AI and the TaBlitz Platform to accelerate tablet development and reduce scale-up risk.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Certara provides modeling, simulation, and regulatory science software for pharmaceutical R&D. Comparable to TaBlitz as a software/AI vendor serving pharmaceutical development and regulatory workflows across the development lifecycle.

TypeEmerging player
Description

dsm-firmenich provides formulation and ingredient solutions for pharma and nutrition, including oral solid dose platforms. Comparable to TaBlitz in serving tablet/nutraceutical formulation development and scale-up, with overlap in the nutraceutical customer segment.

TypeBroad incumbent
Description

Malvern Panalytical supplies particle characterization and analytical instruments used in pharmaceutical powder and tablet analysis. Comparable to TaBlitz as a technology provider serving pharmaceutical powder characterization and formulation analytics.

TypeDirect peer
Description

Simulations Plus provides modeling and simulation software for pharmaceutical R&D, including formulation and ADMET prediction. Comparable to TaBlitz as an AI/software vendor serving pharmaceutical formulation, development, and regulatory workflows.

TypeDirect peer
Description

Schrödinger provides AI-driven physics-based molecular simulation and materials informatics platforms for pharmaceutical R&D. Comparable to TaBlitz in applying AI/ML to pharmaceutical development workflows, though Schrödinger focuses on molecular design while TaBlitz targets formulation and tablet design.

TypeDirect peer
Description

Alcami is a CDMO offering drug development, formulation, and analytical services across small and large molecules. Comparable to TaBlitz as a CDMO peer with formulation development and analytical characterization capabilities.

TypeDirect peer
Description

Cambrex is a CDMO providing API development, formulation, and analytical services for small molecule pharmaceuticals. Comparable to TaBlitz in pharmaceutical development services for OSD formulation and characterization.

TypeBroad incumbent
Description

Patheon, now part of Thermo Fisher, is a global CDMO offering pharmaceutical development and commercial manufacturing services including OSD formulation. Comparable to TaBlitz as a CDMO competitor in formulation development, though at vastly larger scale and broader service portfolio.

TypeRegional player
Description

FREUND-VECTOR manufactures compaction simulation equipment and granulation technology used in tablet development and scale-up. Comparable to TaBlitz in serving the tablet formulation and compaction development workflow, though as a hardware/equipment provider rather than AI software.

TypeDirect peer
Description

Quotient Sciences is a formulation development and CDMO focused on oral solid dose and integrated drug development services. Comparable to TaBlitz in the formulation development and scale-up support market for pharma clients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TaBlitz Labs

Pharmaceutical Formulation Technologytablitz.us

TaBlitz Labs is a U.S. pharmaceutical technology company offering AI-driven tablet formulation development, powder characterization, and scale-up services to pharmaceutical, nutraceutical, and animal health organizations, alongside technology licensing to CDMOs and CMOs.

What TaBlitz Labs does

TaBlitz Labs is a U.S.-based pharmaceutical technology company founded in 2023 and headquartered in St. Louis. It operates as an "AI CDMO partner," providing formulation development, analytical, and material characterization services to pharmaceutical, nutraceutical, and animal health organizations. The company serves two customer tracks: end-user organizations seeking preformulation through scale-up formulation support, and contract development and manufacturing organizations (CDMOs/CMOs) that license the company's technology to deliver AI-driven tablet development capabilities to their own clients.

The company's core technology comprises two components: TaBlitz AI, a deep learning engine applied to tablet design and optimization that delivers data-driven recommendations for manufacturability, tool life, and performance; and the TaBlitz Platform for particle and tablet analytics, built on powder characterization practice aligned with USP <1062> and Pharmeuropa 5.44. These are complemented by Formulation and Development Services including preformulation, formulation development, and troubleshooting grounded in rigorous powder characterization. Revenue is generated through two streams: professional services engagements and technology licensing/implementation for CDMOs and CMOs. Pricing is not publicly disclosed and follows a contact-sales model. The go-to-market motion is sales-led, supported by participation in specialist training programs and the Compaction Simulation Forum, direct enterprise outreach, and a website displaying an enterprise customer logo lineup spanning Pfizer, Vertex Pharmaceuticals, Zentiva, Catalent, Haleon, Alkaloid Pharmaceuticals, Pharma Nord, Takeda, and Elanco.

TaBlitz Labs firmographics

Firmographics
Name
TaBlitz Labs
Legal name
TaBlitz Labs
Website
https://tablitz.us
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
1–10 employees
Short description
TaBlitz Labs is a U.S. pharmaceutical technology company offering AI-driven tablet formulation development, powder characterization, and scale-up services to pharmaceutical, nutraceutical, and animal health organizations, alongside technology licensing to CDMOs and CMOs.
Ownership category
akta.pro rank

TaBlitz Labs industry classification

Industry
Product category
Pharmaceutical Formulation Technology
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Analytical Laboratory Instrument Manufacturing (334516), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAIALAD
CMC & Pharmaceutical Development (Formulation/Process/Analytical Development)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)

Keywords

  • Pharmaceutical formulation services
  • Tablet development AI
  • Powder characterization
  • CDMO technology platform
  • Analytical method development

Where TaBlitz Labs is headquartered

Location

Headquarters

HQ city
St Louis
HQ country
United States
HQ region
North America

Markets served

TaBlitz Labs business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Formulation and Development Services: Preformulation, formulation development, and troubleshooting services grounded in rigorous powder characterization and aligned with regulatory expectations, targeting organizations seeking formulation support and development services.
  2. Technology Licensing and Implementation: Technology implementation services for CDMOs and CMOs who want to implement TaBlitz technology to offer the full TaBlitz advantage to their own clients, including platform access and AI capabilities.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

TaBlitz Labs product offering

Product offering

Core offering

TaBlitz Labs operates as an AI CDMO partner delivering formulation development services alongside a proprietary software platform (TaBlitz AI and TaBlitz Platform) for tablet and powder characterization. The company combines deep learning, formulation science, and mechanical principles to help pharmaceutical and nutraceutical organizations accelerate tablet development, reduce scale-up risk, and align with regulatory references including USP <1062> and Pharmeuropa 5.44. Revenue is generated through formulation/development services, technology licensing and implementation, and equipment sales/instrument partnerships.

Product overview

TaBlitz Labs offers a unified platform architecture centered on the TaBlitz AI engine and TaBlitz Platform for particle and tablet analytics. TaBlitz AI applies deep learning to tablet design and optimization, delivering data-driven recommendations for manufacturability, tool life, and performance. The TaBlitz Platform supports particle and tablet analytics built on powder characterization practice aligned with USP <1062> and Pharmeuropa 5.44. These technology offerings are complemented by Formulation & Development Services covering preformulation through scale-up.

Differentiator

Problem solved

Functional benefit

Products and services

  • TaBlitz AI Proprietary deep-learning model that supports tablet and powder formulation development for pharmaceutical, nutraceutical, and CDMO organizations.
  • TaBlitz Platform Software platform for automated tablet and powder characterization, designed to integrate with laboratory instruments and align with regulatory references such as USP <1062> and Pharmeuropa 5.44.
  • Formulation and Development Services Professional formulation and development services delivered by TaBlitz Labs as an AI CDMO partner, leveraging TaBlitz AI and the TaBlitz Platform to accelerate tablet development and reduce scale-up risk.

Quantifiable outcome

  • Reduces development time through holistic, science-driven approaches and comprehensive characterization
  • +1 more outcomes

Companies that use TaBlitz Labs

Customer profile

Named customers9 records

Segments3 records

Ideal customer profiles3 records

TaBlitz Labs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

TaBlitz Labs partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights4 records

TaBlitz Labs competitors and assessment

Company assessment

Broad incumbents

  • Certara: Certara provides modeling, simulation, and regulatory science software for pharmaceutical R&D. Comparable to TaBlitz as a software/AI vendor serving pharmaceutical development and regulatory workflows across the development lifecycle.
  • Malvern Panalytical: Malvern Panalytical supplies particle characterization and analytical instruments used in pharmaceutical powder and tablet analysis. Comparable to TaBlitz as a technology provider serving pharmaceutical powder characterization and formulation analytics.
  • Patheon (Thermo Fisher Scientific): Patheon, now part of Thermo Fisher, is a global CDMO offering pharmaceutical development and commercial manufacturing services including OSD formulation. Comparable to TaBlitz as a CDMO competitor in formulation development, though at vastly larger scale and broader service portfolio.

Emerging players

  • Firmenich (now dsm-firmenich): dsm-firmenich provides formulation and ingredient solutions for pharma and nutrition, including oral solid dose platforms. Comparable to TaBlitz in serving tablet/nutraceutical formulation development and scale-up, with overlap in the nutraceutical customer segment.

Direct peers

  • Simulations Plus: Simulations Plus provides modeling and simulation software for pharmaceutical R&D, including formulation and ADMET prediction. Comparable to TaBlitz as an AI/software vendor serving pharmaceutical formulation, development, and regulatory workflows.
  • Schrödinger: Schrödinger provides AI-driven physics-based molecular simulation and materials informatics platforms for pharmaceutical R&D. Comparable to TaBlitz in applying AI/ML to pharmaceutical development workflows, though Schrödinger focuses on molecular design while TaBlitz targets formulation and tablet design.
  • Alcami Corporation: Alcami is a CDMO offering drug development, formulation, and analytical services across small and large molecules. Comparable to TaBlitz as a CDMO peer with formulation development and analytical characterization capabilities.
  • Cambrex: Cambrex is a CDMO providing API development, formulation, and analytical services for small molecule pharmaceuticals. Comparable to TaBlitz in pharmaceutical development services for OSD formulation and characterization.
  • Quotient Sciences: Quotient Sciences is a formulation development and CDMO focused on oral solid dose and integrated drug development services. Comparable to TaBlitz in the formulation development and scale-up support market for pharma clients.

Regional players

  • FREUND-VECTOR: FREUND-VECTOR manufactures compaction simulation equipment and granulation technology used in tablet development and scale-up. Comparable to TaBlitz in serving the tablet formulation and compaction development workflow, though as a hardware/equipment provider rather than AI software.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

TaBlitz Labs social profiles

Digital presence

TaBlitz Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TaBlitz Labs leadership team

Management profile

Number of profiles

TaBlitz Labs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TaBlitz Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TaBlitz Labs

What does TaBlitz Labs do?

TaBlitz Labs operates as an AI CDMO partner delivering formulation development services alongside a proprietary software platform (TaBlitz AI and TaBlitz Platform) for tablet and powder characterization. The company combines deep learning, formulation science, and mechanical principles to help pharmaceutical and nutraceutical organizations accelerate tablet development, reduce scale-up risk, and align with regulatory references including USP <1062> and Pharmeuropa 5.44. Revenue is generated through formulation/development services, technology licensing and implementation, and equipment sales/instrument partnerships.

Is TaBlitz Labs a public or private company?

TaBlitz Labs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was TaBlitz Labs founded?

TaBlitz Labs was founded in 2023. It employs 1 to 10 people.

Where is TaBlitz Labs based?

TaBlitz Labs is headquartered in St Louis, United States, in the North America region.

How does TaBlitz Labs make money?

Two revenue lines are on record. Formulation and Development Services are the primary driver. The others are technology Licensing and Implementation.

Who are TaBlitz Labs's main competitors?

Broad incumbents on record are Certara, Malvern Panalytical and Patheon (Thermo Fisher Scientific). Firmenich (now dsm-firmenich) is listed as an emerging player. Direct peers are Simulations Plus, Schrödinger, Alcami Corporation, Cambrex and Quotient Sciences. FREUND-VECTOR is listed as a regional player.

Does TaBlitz Labs have an API?

No public API is recorded for TaBlitz Labs.

What industry is TaBlitz Labs in?

TaBlitz Labs's product category is Pharmaceutical Formulation Technology. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 325412 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales